On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
On Nov. 10, 2025, Canada has lost its measles elimination status after nearly three decades due to its…
On Nov. 10, 2025, the Food and Drug Administration (FDA) is reversing a 2003 decision that put a…
On Nov. 9, 2025, scientists from the Center for Marine Environmental Sciences, University of Bremen reported they had…
On Nov. 7, 2025, Fang Lei, Ph.D., a long-time professor with Texas A&M University’s chemistry department, has returned…
On Nov. 7, 2025, research published today in Cell Reports Medicine reveals key biological differences that may explain why…
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
On Nov. 6, 2025, scientists from Oxford’s Radcliffe Department of Medicine have achieved the most detailed view yet…
On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…
On Nov. 5, 2025, a large study of adults with type 2 diabetes showed that those who consistently…
On Nov. 5, 2025, an Osaka Metropolitan University team has used stem cells extracted from adipose, the body’s…
On Nov. 5, 2025, researchers announced that reading a person’s mind using a recording of their brain activity…
On Nov. 5, 2025, MIT researchers announced they have developed a new 3D human brain tissue platform, the…
On Nov. 5, 2025, the World Health Organization (WHO) reported that between 20 September and 30 October 2025,…
On Nov. 4, 2025, Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and…
On Nov. 4, 2025, six years ago this month, scientists launched a massively ambitious effort to sequence the…
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
On Nov. 4, 2025, a team of scientists led by the University of Washington announced findings published this…
On Nov. 3, 2025, United Therapeutics, a public benefit corporation, announced the first clinical xenotransplantation in its EXPAND…
On Nov. 3, 2025, scientists at the University of California, San Diego (UC San Diego) announced they have…
On Nov. 3, 2025, Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about…
On Oct. 31, 2025, investigators from Mass General Brigham, the Broad Institute of MIT and Harvard, and VA…
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
On Oct. 30, 2025, researchers at Virginia Commonwealth University and VCU Health announced preliminary study findings that show…
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…